Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012817) titled 'Effectiveness of a Health Management App Using Wearable Device Data for Breast Cancer Survivors' on Oct. 21.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Yonsei University
Condition:
Neoplasms
Intervention:
Behavioral : The intervention group was provided with a Galaxy Fit and used the ReBloomLens app, developed by the research team, for 4 weeks to manage and adhere to exercise and sleep recommendations. The control group was similarly provided with a Galaxy Fit
Recruitment Status: Not ...